Innocoll AG Secures EUR 25 Million Loan Commitment From European Investment Bank (EIB)
30. März 2015 07:00 ET
|
Innocoll Holdings plc
EIB's InnovFin Financing Supports Innovative Companies under Horizon 2020
Financing to Support Manufacturing Facility Expansion and Development of Lead Product Candidates
ATHLONE, Ireland, March...
Innocoll AG Announces Fourth Quarter and Full Year 2014 Financial and Operating Results
19. März 2015 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, March 19, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...
Innocoll AG Appoints James Tursi, M.D., as Chief Medical Officer
18. März 2015 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, March 18, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) today announced that James Tursi, M.D., has been appointed chief medical officer. Dr. Tursi will be responsible for...
Innocoll to Report Fourth Quarter and Full Year 2014 Financial Results and Host Webcast and Conference Call on March 19, 2015
13. März 2015 16:15 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, March 13, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll AG Appoints Tony Zook as Chief Executive Officer as Company Progresses Toward Becoming a Fully-Integrated Commercial Company
08. Dezember 2014 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) today announced that Tony Zook, formerly executive vice president, Global Commercial Operations, at AstraZeneca, has been...
Innocoll AG Announces Third Quarter 2014 Financial and Operating Results
13. November 2014 08:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...
Innocoll to Report Third Quarter 2014 Financial Results and Host Webcast and Conference Call on November 13, 2014
06. November 2014 16:05 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll AG Proposes Changes to Supervisory Board and Stock Option Plan
22. Oktober 2014 16:30 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, Oct. 22, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...
Innocoll AG Announces Closing of Initial Public Offering
30. Juli 2014 17:39 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, July 30, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll AG Announces Pricing of Initial Public Offering
25. Juli 2014 07:00 ET
|
Innocoll Holdings plc
ATHLONE, Ireland, July 25, 2014 (GLOBE NEWSWIRE) -- Innocoll AG (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of pharmaceutical...